...We Welcome You To The Resverlogix HUB In The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** BETonMACE Trial is Fully Enrolled and Expected to be Completed H1 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Free
Message: Now that we're a small cap stock....

After BETonMACE top line data release there will be presentation(s) and publication(s) of the full BETonMACE trial data at major conferences and in major journals. Assuming top line is positive, then the full reveal of the detailed outcomes and safety data as well as all of the sub-studies and pre-specified comparisons would offer even more potential headlines/spotlights/catalysts. Top line is only the beginning, if not the end.

BearDownAZ 

Share
New Message
Please login to post a reply